Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamanna Lakhanpal

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 3, 2018
Radiation Exposure to the Personnel Performing Robotic Arm-Assisted Positron Emission Tomography/Computed Tomography-Guided BiopsiesTamanna Lakhanpal, Bhagwant Rai Mittal, Rajender Kumar, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|February 2, 2026
Potential role of <sup>68</sup>Ga- and <sup>177</sup>Lu-cyclic pentapeptides for in-vivo targeting CXCR4 receptor expression in chemotherapy relapse MCL patientTamanna Lakhanpal, Bhagwant Rai Mittal, Jaya Shukla, et al.
Nuclear Medicine Communications|June 17, 2025
Bifunctional chelator-plerixafor complex for targeting CXCR4 receptors: radiolabeling, in-vitro, and preclinical studyTamanna Lakhanpal, Jaya Shukla, Rajender Kumar, et al.
Nuclear Medicine Communications|April 1, 2022
Nuclear medicine in the management of superficial skin abnormalities and institutional experienceAnupriya Chhabra, Somit Pandey, Yogesh Rathore, et al.
Clinical Nuclear Medicine|April 5, 2024
Targeting Breast Cancer Using 177 Lu-Labeled Trastuzumab and Trastuzumab Fragment : First-in-Human Clinical ExperienceYogesh Rathore, Tamanna Lakhanpal, Sudipta Chakraborty, et al.
Nuclear Medicine Communications|February 8, 2022
Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patientsYogesh Rathore, Jaya Shukla, Ishita Laroiya, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 3, 2018
Radiation Exposure to the Personnel Performing Robotic Arm-Assisted Positron Emission Tomography/Computed Tomography-Guided BiopsiesTamanna Lakhanpal, Bhagwant Rai Mittal, Rajender Kumar, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|February 2, 2026
Potential role of <sup>68</sup>Ga- and <sup>177</sup>Lu-cyclic pentapeptides for in-vivo targeting CXCR4 receptor expression in chemotherapy relapse MCL patientTamanna Lakhanpal, Bhagwant Rai Mittal, Jaya Shukla, et al.
Nuclear Medicine Communications|June 17, 2025
Bifunctional chelator-plerixafor complex for targeting CXCR4 receptors: radiolabeling, in-vitro, and preclinical studyTamanna Lakhanpal, Jaya Shukla, Rajender Kumar, et al.
Nuclear Medicine Communications|April 1, 2022
Nuclear medicine in the management of superficial skin abnormalities and institutional experienceAnupriya Chhabra, Somit Pandey, Yogesh Rathore, et al.
Clinical Nuclear Medicine|April 5, 2024
Targeting Breast Cancer Using 177 Lu-Labeled Trastuzumab and Trastuzumab Fragment : First-in-Human Clinical ExperienceYogesh Rathore, Tamanna Lakhanpal, Sudipta Chakraborty, et al.
Nuclear Medicine Communications|February 8, 2022
Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patientsYogesh Rathore, Jaya Shukla, Ishita Laroiya, et al.
Pageof 1